H1B Salary Data

Home › Employers › Avista Pharma Solutions, Inc.

Avista Pharma Solutions, Inc.: H-1B salaries and sponsorship

Avista Pharma Solutions, Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $77,251.

Applications (LCAs)3
Certified3
Employer addressDurham, NC
H-1B dependent employerNo
Median offered salary$77,251
Middle half of salaries$77,251–$83,626
10th–90th percentile$77,251–$87,450

Does Avista Pharma Solutions, Inc. sponsor H-1B visas?

Avista Pharma Solutions, Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Jun 6, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Sr. Scientist II (ARD)2$77,251
Associate Scientist II (Formulations)1$90,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20241$90,000
FY20252$77,251

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Sr. Scientist II (ARD)$77,251–$89,560
Level II
Durham, NCJun 6, 2025Oct 1, 2025Certified
Sr. Scientist II (ARD)$77,251–$89,560
Level II
Durham, NCMay 15, 2025Jun 16, 2025Certified
Associate Scientist II (Formulations)$90,000–$120,000
Level II
Longmont, CODec 22, 2023Jan 22, 2024Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).